195 related articles for article (PubMed ID: 37676741)
1. Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis.
Matte A; Wilson AB; Gevi F; Federti E; Recchiuti A; Ferri G; Brunati AM; Pagano MA; Russo R; Leboeuf C; Janin A; Timperio AM; Iolascon A; Gremese E; Dang L; Mohandas N; Brugnara C; De Franceschi L
JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37676741
[TBL] [Abstract][Full Text] [Related]
2. Mitapivat: A Quinolone Sulfonamide to Manage Hemolytic Anemia in Adults With Pyruvate Kinase Deficiency.
Wills J; Horenstein M; Kim A; Silva MA; Dima L
Am J Ther; 2023 Sep-Oct 01; 30(5):e433-e438. PubMed ID: 37713687
[TBL] [Abstract][Full Text] [Related]
3. Mitapivat: A Review in Pyruvate Kinase Deficiency in Adults.
Zhuang-Yan A; Shirley M
Drugs; 2023 Nov; 83(17):1613-1620. PubMed ID: 37991635
[TBL] [Abstract][Full Text] [Related]
4. The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model.
Matte A; Federti E; Kung C; Kosinski PA; Narayanaswamy R; Russo R; Federico G; Carlomagno F; Desbats MA; Salviati L; Leboeuf C; Valenti MT; Turrini F; Janin A; Yu S; Beneduce E; Ronseaux S; Iatcenko I; Dang L; Ganz T; Jung CL; Iolascon A; Brugnara C; De Franceschi L
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33822774
[TBL] [Abstract][Full Text] [Related]
5. Mild spherocytosis and altered red cell ion transport in protein 4. 2-null mice.
Peters LL; Jindel HK; Gwynn B; Korsgren C; John KM; Lux SE; Mohandas N; Cohen CM; Cho MR; Golan DE; Brugnara C
J Clin Invest; 1999 Jun; 103(11):1527-37. PubMed ID: 10359562
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell aquaporin-1 expression is decreased in hereditary spherocytosis.
Crisp RL; Maltaneri RE; Vittori DC; Solari L; Gammella D; Schvartzman G; García E; Rapetti MC; Donato H; Nesse A
Ann Hematol; 2016 Oct; 95(10):1595-601. PubMed ID: 27465156
[TBL] [Abstract][Full Text] [Related]
7. Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias.
Al-Samkari H; van Beers EJ
Ther Adv Hematol; 2021; 12():20406207211066070. PubMed ID: 34987744
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of hereditary spherocytosis by multi-gene target sequencing in Korea: matching with osmotic fragility test and presence of spherocyte.
Choi HS; Choi Q; Kim JA; Im KO; Park SN; Park Y; Shin HY; Kang HJ; Kook H; Kim SY; Kim SJ; Kim I; Kim JY; Kim H; Park KD; Park KB; Park M; Park SK; Park ES; Park JA; Park JE; Park JK; Baek HJ; Seo JH; Shim YJ; Ahn HS; Yoo KH; Yoon HS; Won YW; Lee KS; Lee KC; Lee MJ; Lee SA; Lee JA; Lee JM; Lee JH; Lee JW; Lim YT; Jung HJ; Chueh HW; Choi EJ; Jung HL; Kim JH; Lee DS;
Orphanet J Rare Dis; 2019 May; 14(1):114. PubMed ID: 31122244
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency.
Song AB; Al-Samkari H
Expert Rev Hematol; 2022 Oct; 15(10):875-885. PubMed ID: 36124781
[TBL] [Abstract][Full Text] [Related]
10. [Hereditary spherocytosis].
Ideguchi H
Nihon Rinsho; 1996 Sep; 54(9):2478-83. PubMed ID: 8890582
[TBL] [Abstract][Full Text] [Related]
11. Correspondence.
Brodsky I; Reilly CA; Schloss GT
Cancer Res; 1971 Oct; 31(10):1513-4. PubMed ID: 5095136
[No Abstract] [Full Text] [Related]
12. Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency.
van Beers EJ; Al-Samkari H; Grace RF; Barcellini W; Glenthøj A; DiBacco M; Wind-Rotolo M; Xu R; Beynon V; Patel P; Porter JB; Kuo KHM
Blood Adv; 2024 May; 8(10):2433-2441. PubMed ID: 38330179
[TBL] [Abstract][Full Text] [Related]
13. Human erythrocyte protein 4.2 deficiency associated with hemolytic anemia and a homozygous 40glutamic acid-->lysine substitution in the cytoplasmic domain of band 3 (band 3Montefiore).
Rybicki AC; Qiu JJ; Musto S; Rosen NL; Nagel RL; Schwartz RS
Blood; 1993 Apr; 81(8):2155-65. PubMed ID: 8471774
[TBL] [Abstract][Full Text] [Related]
14. Hereditary spherocytosis is associated with decreased pyruvate kinase activity due to impaired structural integrity of the red blood cell membrane.
Andres O; Loewecke F; Morbach H; Kraus S; Einsele H; Eber S; Speer CP
Br J Haematol; 2019 Nov; 187(3):386-395. PubMed ID: 31273765
[TBL] [Abstract][Full Text] [Related]
15. Targeted next-generation sequencing identifies novel deleterious variants in ANK1 gene causing severe hereditary spherocytosis in Indian patients: expanding the molecular and clinical spectrum.
More TA; Devendra R; Dongerdiye R; Warang P; Kedar P
Mol Genet Genomics; 2023 Mar; 298(2):427-439. PubMed ID: 36598564
[TBL] [Abstract][Full Text] [Related]
16. Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis.
Berrevoets MC; Bos J; Huisjes R; Merkx TH; van Oirschot BA; van Solinge WW; Verweij JW; Lindeboom MYA; van Beers EJ; Bartels M; van Wijk R; Rab MAE
Front Physiol; 2021; 12():641384. PubMed ID: 33841180
[TBL] [Abstract][Full Text] [Related]
17. Inherited erythrocyte metabolic and membrane disorders.
Brewer GJ
Med Clin North Am; 1980 Jul; 64(4):579-96. PubMed ID: 6995724
[TBL] [Abstract][Full Text] [Related]
18. Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry.
Vives-Corrons JL; Krishnevskaya E; Rodriguez IH; Ancochea A
Int J Hematol; 2021 Feb; 113(2):163-174. PubMed ID: 33074480
[TBL] [Abstract][Full Text] [Related]
19. Mitapivat for sickle cell disease and thalassemia.
Pilo F; Angelucci E
Drugs Today (Barc); 2023 Mar; 59(3):125-134. PubMed ID: 36847623
[TBL] [Abstract][Full Text] [Related]
20. Red cell membrane Na+ transport systems in hereditary spherocytosis: relevance to understanding the increased Na+ permeability.
Vives Corrons JL; Besson I
Ann Hematol; 2001 Sep; 80(9):535-9. PubMed ID: 11669303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
